Evommune, Inc. (EVMN)

NYSE: EVMN · Real-Time Price · USD

12.66

-0.57 (-4.31%)

At close: Aug 31, 2026, 4:00 PM EDT

12.60

-0.06 (-0.47%)

After-hours: Aug 31, 2026, 7:36 PM EDT

Evommune Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023
Cash & Equivalents	60.03	44.06	16.26	29.02
Short-Term Investments	140.76	105.14	55.79	50.06
Cash & Short-Term Investments	200.79	149.2	72.04	79.08
Cash Growth	131.34%	107.11%	-8.91%	-
Prepaid Expenses	3.45	4.28	1.95	0.95
Total Current Assets	204.25	153.48	73.99	80.03
Property, Plant & Equipment	9.22	2.46	1.8	1.97
Long-Term Investments	87.21	67.49	-	-
Other Long-Term Assets	1.27	1.52	0.27	0.25
Total Assets	301.95	224.95	76.06	82.25

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023
Accounts Payable	5.04	7.76	8.26	1.76
Accrued Expenses	10.69	9.55	6.73	4.03
Current Portion of Leases	1.76	0.59	0.49	0.77
Current Unearned Revenue	-	-	3	-
Other Current Liabilities	-	0.02	9.5	0.3
Total Current Liabilities	17.49	17.91	27.98	6.86
Long-Term Leases	6.87	1.47	0.54	0.49
Long-Term Deferred Tax Liabilities	-	-	-	3
Other Long-Term Liabilities	-	-	-	0.25
Total Liabilities	24.36	19.38	28.52	10.59

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023
Common Stock	0	0	-	0
Additional Paid-In Capital	552.59	426.65	7.98	6.2
Retained Earnings	-275.01	-221.09	-152.22	-83.91
Total Common Equity	277.59	205.57	-144.24	-77.71
Shareholders' Equity	277.59	205.57	47.54	71.66
Total Liabilities & Equity	301.95	224.95	76.06	82.25

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023
Total Debt	8.63	2.06	1.02	1.26
Net Cash (Debt)	192.16	147.14	71.02	77.83
Net Cash Growth	123.38%	107.19%	-8.75%	-
Net Cash Per Share	8.42	23.98	47.09	62.10
Filing Date Shares Outstanding	36.29	36.02	1.55	1.25
Total Common Shares Outstanding	36.28	31.52	1.55	1.25
Working Capital	186.76	135.57	46.01	73.18
Book Value Per Share	7.65	6.52	-92.97	-62.01
Tangible Book Value	277.59	205.57	-144.24	-77.71
Tangible Book Value Per Share	7.65	6.52	-92.97	-62.01
Machinery	0.96	0.83	0.67	-
Construction In Progress	0.04	0.04	-	-
Leasehold Improvements	0.54	0.53	0.46	-

SEC Filings: 10-K · 10-Q